Exploring heterogeneity in clinical trials with latent class analysis.

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Health Outcomes Research

Background:

• Clinical trials often have complex patient subgroups (case-mix) where treatment effects may differ.
• Traditional subgroup analyses are limited in exploring high-order interactions among confounding variables.
• Latent class analysis (LCA) offers a robust framework to identify unobserved patient clusters based on manifest variables.

Discussion:

• LCA enables the identification of distinct patient latent classes, moving beyond simple subgroup definitions.
• This approach allows for the exploration of differential treatment effects on distal clinical outcomes across identified classes.
• The 'classify-analyze' strategy integrates class identification with outcome analysis for deeper insights.

Key Insights:

• LCA effectively uncovers hidden patient heterogeneity relevant to treatment response.
• Differential treatment effects across latent classes can be quantitatively assessed.
• This methodology enhances the precision of subgroup analysis in clinical research.

Outlook:

• Implementing LCA can refine patient stratification and personalize treatment strategies.
• Future research can leverage LCA to explore complex interactions in diverse clinical settings.
• The R tutorial provides a practical guide for applying LCA in real-world clinical trial data analysis.